Meluzio Michael Vincent

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Meluzio Michael Vincent's trades of Cue Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
184.50
Quantity 95,747 -10.0%
Value US$2,300,071
Transaction date
Sale
Price
379.68
Quantity 22,752 -27.3%
Value US$760,674
Transaction date
Sale
Price
178.77
Quantity 74,307 -46.9%
Value US$4,004,299
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-13
S Sale
95,747 -10.0%
184.50
US$2,300,071 		95,747 -10.0% 184.50 US$2,300,071
2026-08-17 2026-08-13
S Sale
22,752 -27.3%
379.68
US$760,674 		22,752 -27.3% 379.68 US$760,674
2026-08-17 2026-08-13
S Sale
74,307 -46.9%
178.77
US$4,004,299 		74,307 -46.9% 178.77 US$4,004,299